We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sientra Inc | NASDAQ:SIEN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.174 | 0.1668 | 0.1816 | 0 | 01:00:00 |
From May 2022 to May 2024
By Chris Wack
Sientra Inc. said the U.S. Food and Drug Administration approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.
The company said the product will be commercially available for board-certified and board-eligible plastic surgeons in the U.S. in late July.
Sientra shares were up 13% to 99 cents in premarket trading.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
July 06, 2022 09:29 ET (13:29 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Sientra Chart |
1 Month Sientra Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
